- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Nonsteroidal Aromatase Inhibitor (NSAI)
Total 2552 results
-
University of Alabama at BirminghamGenentech, Inc.; Breast Cancer Research FoundationCompletedBreast Cancer | Breast Neoplasm | Cancer of the BreastUnited States
-
National University Hospital, SingaporeEisai Co., Ltd.Recruiting
-
Guangdong Provincial People's HospitalNot yet recruitingNeoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer
-
Kyowa Kirin Co., Ltd.CompletedAdvanced or Recurrent Breast CancerJapan
-
Rovi Pharmaceuticals LaboratoriesRecruiting
-
International Peace Maternity and Child Health...RecruitingInfertility, Female | LetrozoleChina
-
First Affiliated Hospital of Zhejiang UniversityRecruitingBreast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive TumorChina
-
Eli Lilly and CompanyRecruitingBreast Neoplasms | Neoplasm MetastasisJapan, United States, China, Czechia, Belgium, Brazil, Germany, Netherlands, Russian Federation, Ukraine, Taiwan, France, Korea, Republic of, Italy, Spain, Australia, Turkey, India, Argentina, Greece, Austria, Mexico
-
Erasme University HospitalUniversity Hospital, LilleRecruitingBreast Neoplasm Malignant FemaleFrance, Italy, Belgium
-
Cairo UniversityCompletedPolycystic Ovary SyndromeEgypt
-
Universiti Kebangsaan Malaysia Medical CentreCompletedMiscarriage, RecurrentMalaysia
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerGermany
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
The Affiliated Hospital of Qingdao UniversityUnknownBioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Volunteers Under Fed ConditionHealthy VolunteersChina
-
M.D. Anderson Cancer CenterSusan G. Komen Breast Cancer FoundationTerminated
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerSweden, United States, Russian Federation, South Africa, United Kingdom, Germany, Hungary, Canada, Belgium, Denmark, Israel, Argentina, France, Brazil, Spain
-
National Cancer Center, KoreaCompletedGoserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBCMetastatic Breast CancerKorea, Republic of
-
AstraZenecaCompleted
-
AstraZenecaCompletedBreast CancerGermany, Norway, Austria
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingRheumatoid Arthritis
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
National Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Maryland, BaltimoreGlaxoSmithKline; Novartis PharmaceuticalsTerminatedBreast Neoplasms | Neoplasm Metastasis | Endocrine Breast DiseasesUnited States
-
Mayo ClinicRecruitingInvasive Breast Carcinoma | Breast Adenocarcinoma | Resectable Breast CarcinomaUnited States
-
University of CincinnatiRecruiting
-
Eli Lilly and CompanyActive, not recruitingBreast CancerChina, India, South Africa, Brazil
-
Novartis PharmaceuticalsCompleted
-
University of Michigan Rogel Cancer CenterDamon Runyon Cancer Research FoundationCompletedPain | Breast Cancer | ArthralgiaUnited States
-
Shanghai Jiao Tong University School of MedicineCompleted
-
Nishtar Medical UniversityCompletedPolycystic Ovary SyndromePakistan
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Spain, Belgium, Hong Kong, France
-
Institut BergoniéNational Cancer Institute, FranceCompleted
-
Shanghai Jiao Tong University School of MedicineCompletedBreast Cancer | OsteoporosisChina
-
Novartis PharmaceuticalsCompletedPost Menopausal Breast CancerTaiwan, Malaysia, Turkey, Australia, Korea, Republic of, Thailand, Jordan, India, Vietnam, Morocco, Tunisia, Indonesia, South Africa
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Cancer and Leukemia Group BCompleted
-
Ruijin HospitalJiangsu HengRui Medicine Co., Ltd.UnknownBreast Cancer | HER2-positive Breast Cancer | ER-positive Breast Cancer
-
Georgetown UniversityTerminatedBreast Cancer | Neoplasms, Breast | Cancer of the BreastUnited States
-
Mayo ClinicCompleted
-
Center for Human ReproductionWithdrawnInfertilityUnited States
-
AstraZenecaCompletedBreast CancerSweden, France, Italy, Turkey, Germany, Norway, Finland, Portugal, Canada, Iceland, Costa Rica, Guatemala
-
University of MonastirCompleted
-
Olema Pharmaceuticals, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2 Negative Breast Carcinoma | ER Positive Breast CancerUnited States, Korea, Republic of, Australia, Taiwan, Hong Kong, Malaysia, Thailand, Argentina, Belgium, Portugal, Italy, Czechia, Mexico, Poland
-
Dana-Farber Cancer InstituteEli Lilly and CompanyRecruitingEndometrial CancerUnited States
-
Boehringer IngelheimActive, not recruitingNeoplasms | Breast NeoplasmsUnited States, Spain, Korea, Republic of, Finland, Japan, Denmark, France
-
Jagiellonian UniversityCompleted
-
SOLTI Breast Cancer Research GroupPierre Fabre LaboratoriesCompleted
-
University of ArizonaNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Novartis PharmaceuticalsCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed